Claims
- 1. An antiviral glove consisting essentially of an elastomeric hand-shaped body having interior and exterior surfaces and an inner coating disposed on the interior surface of the elastomeric body, wherein the inner coating comprises (a) an antiinfective agent selected from the group consisting of chlorhexidine and pharmaceutically acceptable salts of chlorhexidine and (b) a lubricating agent which does not significantly adsorb the antiinfective agent, said inner coating being effective to deliver an antivirally effective amount of the antiinfective agent within ten minutes of exposure to a liquid.
- 2. An antiviral glove according to claim 1, wherein the delivery of antiinfective agent from the inner coating is substantially complete within ten minutes of exposure to liquid.
- 3. An antiviral glove according to claim 1, wherein the lubricating agent is corn starch modified with didecyldimethylammonium chloride.
- 4. An antiviral glove according to claim 3, wherein the elastomeric body is formed from a natural rubber latex.
- 5. An antiviral glove according to claim 4, wherein the natural rubber latex is modified to saturate binding sites for the antiinfective agent in the latex.
- 6. An antiviral glove according to claim 5, wherein the latex is saturated with a material selected from the group selected from metal ions, organic acids and cationic surfactants.
- 7. An antiviral glove according to claim 1, wherein the inner coating further comprises a biomedically acceptable polymer.
- 8. An antiviral glove according to claim 7, wherein the polymer is selected from the group consisting of silicones and polyurethanes.
- 9. An antiviral glove according to claim 1, wherein the elastomeric body is formed from a natural rubber latex.
- 10. An antiviral glove according to claim 9, wherein the natural rubber latex is modified to saturate binding sites for the antiinfective agent in the latex.
- 11. An antiviral glove according to claim 10, wherein the latex is saturated with a material selected from the group consisting of metal ions, organic acids and cationic surfactants.
- 12. An antiviral glove according to claim 1, wherein the lubricating agent is zinc oxide.
- 13. An antiviral glove according to claim 1, wherein the glove contains from 3.0 to 6.5 mg of releasable antiinfective agent.
Parent Case Info
This application is a continuation-in-part of U.S. patent application Ser. No. 258,189, filed Oct. 14, 1988, now U.S. Pat. No. 5,019,096 which is a continuation-in-part of U.S. patent application Ser. No. 154,920 filed Feb. 11, 1988, now abandoned.
US Referenced Citations (10)
Foreign Referenced Citations (2)
Number |
Date |
Country |
WO9001956 |
Mar 1990 |
WOX |
2218617 |
Nov 1989 |
GBX |
Non-Patent Literature Citations (6)
Entry |
Harbison et al., Inactivation of Human Immunodeficiency Virus . . . Journal of Acquired Immune Deficiency . . . (1989), vol. 2, No. 1, pp. 16-20. |
Yamamoto et al., Antiviral Action of Benzalkonium Chloride . . . J. Antibact. Anifung. Agents (1988), vol. 16, No. 11, pp. 505-508. |
Chemical Abstracts (1975) vol. 83, p. 38 71620b. |
Chemical Abstracts (1984) vol. 101, p. 8 221999p. |
Chemical Abstracts (1985) vol. 102, p. 304 128281j. |
Journal of Controlled Release, (1987), 6. pp. 343-352, Elsevier Science Publishers B.V. Amsterdam. |
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
258189 |
Oct 1988 |
|
Parent |
154920 |
Feb 1988 |
|